CD1C and systemic lupus erythematosus: After transplantation of allogenic UC-MSCs, peripheral blood CD1c+ DCs and serum FLT3L can be significantly up-regulated in SLE patients, suggesting that UC-MSCs are useful for SLE treatment by inducing increased resistant CD1c+ DCs (96).